Background Non‐alcoholic steatohepatitis (NASH) is a severe form of non‐alcoholic fatty
liver disease (NAFLD) characterised by liver fat accumulation, inflammation and progressive …

Objective Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …

Non-alcoholic fatty liver disease (NAFLD) is now recognised as the most common liver
disease worldwide. It encompasses a broad spectrum of conditions, from simple steatosis …

Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver
diseases worldwide. It encompasses a spectrum of disorders ranging from isolated hepatic …

Our understanding of nonalcoholic steatohepatitis (NASH) pathophysiology continues to
advance rapidly. Given the complexity of the pathogenesis of NASH, the field has moved …

Introduction An interaction between metabolic triggers and inherited predisposition
underpins the development and progression of non alcoholic fatty liver disease (NAFLD) …

The patatin‐like phosholipase domain‐containing 3 (PNPLA3) rs738409 polymorphism
(I148M) is a major determinant of hepatic fat and predisposes to the full spectrum of liver …

Liver fat accumulation generally related to systemic insulin resistance characterizes
nonalcoholic fatty liver disease (NAFLD), which in the presence of nonalcoholic …

Worldwide non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type
of liver disease and its burden increasing at an alarming rate. NAFLD entails steatosis …

Nonalcoholic steatohepatitis (NASH), an inflammatory subtype of nonalcoholic fatty liver
disease (NAFLD), is featured by significantly elevated levels of various pro-inflammatory …